Antibiotic resistance in Serratia marcescens.
作者信息
Sleigh J D
出版信息
Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1651-3. doi: 10.1136/bmj.287.6406.1651.
Abstract
摘要
相似文献
1
Antibiotic resistance in Serratia marcescens.粘质沙雷氏菌中的抗生素耐药性。
Br Med J (Clin Res Ed). 1983 Dec 3;287(6406):1651-3. doi: 10.1136/bmj.287.6406.1651.
2
3
[Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].粘质沙雷氏菌引起的尿路感染的临床研究。I. 粘质沙雷氏菌引起的尿路感染的临床和细菌学研究
Nihon Hinyokika Gakkai Zasshi. 1983 Apr;74(4):467-84. doi: 10.5980/jpnjurol1928.74.4_467.
4
[Combination of exchange transfusion and directed antibiotic therapy in the treatment of severe sepsis. A case of multi-resistant Serratia marcescens sepsis].
Minerva Pediatr. 1978 May 15;30(9):753-7.
5
Serratia marcescens in a general hospital.一家综合医院里的粘质沙雷氏菌。
Q J Med. 1977 Jan;46(181):63-71.
6
The use of antibiotic combinations in the treatment of Serratia marcescens infections.抗生素联合用药在治疗粘质沙雷氏菌感染中的应用。
J Antimicrob Chemother. 1977 Mar;3(2):193-4. doi: 10.1093/jac/3.2.193.
7
Serratia marcescens septicaemia in newborn.
Indian J Med Res. 1977 May;65(5):623-7.
8
Serratia marcescens infections--selection of an antibiotic.粘质沙雷氏菌感染——抗生素的选择
J Antimicrob Chemother. 1976 Dec;2(4):317-9. doi: 10.1093/jac/2.4.317.
9
Serratia marcescens endocarditis. Report of a patient.
Arch Intern Med. 1970 Jun;125(6):1038-40.
10
[Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].[粘质沙雷氏菌引起的医院感染及其对抗生素的敏感性]
Bol Med Hosp Infant Mex. 1980 Sep-Oct;37(5):871-7.
引用本文的文献
1
Rare post-operative intracranial abscess due to Serratia marcescens: what we can learn from it?罕见的术后颅内脓肿由粘质沙雷氏菌引起：我们能从中吸取什么教训？
BMC Infect Dis. 2024 Jan 8;24(1):61. doi: 10.1186/s12879-023-08966-7.
2
Asparagine biosynthesis as a mechanism of increased host lethality induced by in simulated microgravity environments.天冬酰胺生物合成作为模拟微重力环境中由[具体因素]诱导宿主致死率增加的一种机制。 （注：原文中“by”后面似乎缺少具体内容）
Heliyon. 2022 May 4;8(5):e09379. doi: 10.1016/j.heliyon.2022.e09379. eCollection 2022 May.
3
Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules.与临床批准药物共轭的氧化锌纳米颗粒作为潜在的抗菌分子。
AMB Express. 2021 Jul 10;11(1):104. doi: 10.1186/s13568-021-01261-1.
4
as a Candidate Marker for Transgenerational Immune Priming in a Dampwood Termite (Blattodae: Archeotermopsidae).作为湿木白蚁（蜚蠊目：古白蚁科）跨代免疫致敏的候选标记物。
Insects. 2020 Feb 27;11(3):149. doi: 10.3390/insects11030149.
5
Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains.色素沉着和无色素临床粘质沙雷氏菌菌株的细胞表面疏水性。
Infect Immun. 1986 Mar;51(3):932-5. doi: 10.1128/iai.51.3.932-935.1986.
6
Epidemic outbreak of Serratia marcescens infection in a cardiac surgery unit.心脏外科病房里发生了粘质沙雷氏菌感染的疫情爆发。
J Clin Microbiol. 1987 Jul;25(7):1298-300. doi: 10.1128/jcm.25.7.1298-1300.1987.
7
Clearance of Serratia marcescens from blood in mice: role of hydrophobic versus mannose-sensitive interactions.粘质沙雷氏菌在小鼠血液中的清除：疏水相互作用与甘露糖敏感相互作用的作用
Infect Immun. 1988 May;56(5):1167-70. doi: 10.1128/iai.56.5.1167-1170.1988.
8
Increased cell surface hydrophobicity of a Serratia marcescens NS 38 mutant lacking wetting activity.缺乏湿润活性的粘质沙雷氏菌NS 38突变体的细胞表面疏水性增加。
J Bacteriol. 1988 Sep;170(9):4361-4. doi: 10.1128/jb.170.9.4361-4364.1988.
9
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
本文引用的文献
1
The Type Species of the Genus Serratia, Commonly Known as Bacillus Prodigiosus.沙雷氏菌属的模式种，通常称为灵杆菌。
J Bacteriol. 1924 Nov;9(6):545-57. doi: 10.1128/jb.9.6.545-557.1924.
2
Role of Serratia species in urinary tract infections.沙雷氏菌属在尿路感染中的作用。
Arch Intern Med. 1962 May;109:536-9. doi: 10.1001/archinte.1962.03620170034005.
3
SELDOM-ENCOUNTERED AGENTS OF BACTERIAL MENINGITIS.细菌性脑膜炎的罕见病原体
JAMA. 1965 Jun 14;192:956-60. doi: 10.1001/jama.1965.03080240026005.
4
Mechanisms of resistance to aminoglycosides in clinical isolates.临床分离株中对氨基糖苷类抗生素耐药的机制。
J Antimicrob Chemother. 1982 Feb;9(2):91-102. doi: 10.1093/jac/9.2.91.
5
Characteristics of Serratia marcescens containing a plasmid coding for gentamicin resistance in nosocomial infections.医院感染中携带编码庆大霉素耐药质粒的粘质沙雷氏菌的特征
J Infect Dis. 1981 Jun;143(6):810-7. doi: 10.1093/infdis/143.6.810.
6
Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.重症监护新生儿病房中耐阿米卡星肠杆菌科细菌的暴发。
Pediatrics. 1980 Feb;65(2):264-8.
7
The ototoxic potential of netilmicin compared with amikacin. An animal study in guinea pigs.
Scand J Infect Dis Suppl. 1980;Suppl 23:104-13.
8
Netilmicin in the treatment of neonates with moderate and severe infections.奈替米星治疗新生儿中重度感染
Scand J Infect Dis Suppl. 1980;Suppl 23:146-50.
9
Characterization of spontaneous resistant variants of Serratia marcescens selected in the presence of carbenicillin.在羧苄青霉素存在下筛选出的粘质沙雷氏菌自发抗性变体的特性分析。
J Antimicrob Chemother. 1983 Oct;12(4):329-35. doi: 10.1093/jac/12.4.329.
10
Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.奈替米星：与其他氨基糖苷类药物相比对粘质沙雷菌的体外活性。
J Antimicrob Chemother. 1983 Feb;11(2):187-9. doi: 10.1093/jac/11.2.187.
Zotero 插件